PRODUCT NEWS

ELITechGroup announces the release of SARS-CoV-2 PLUS ELITe MGB® Kit.

ITALY, Torino, December, 15th, 2020. ELITechGroup is pleased to announce the release of SARS-CoV-2 PLUS ELITe MGB® Kit. The Kit is CE-IVD marked and detects SARS-CoV-2, Flu A, Flu B, and RSV on the Sample-to Result-Platform ELITe InGenius® and is available on major PCR thermocyclers as well. The test will complement the menu of 41 CE-IVD certified infectious disease tests on ELITe InGenius® and specifically the panel for the respiratory infections. The SARS-CoV-2 PLUS test was developed to provide a differential diagnosis to distinguish SARS-CoV-2 from other respiratory viruses that may give similar symptoms. The kit detects Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A Virus (FluA), Influenza B Virus (FluB), Respiratory Syncytial Virus type A and type B (RSV). The endogenous Internal Control allows confirming the presence and quality of the sample material extracted.

Roberto Meda, Vice President MDx ELITechGroup, is excited to offer such an important multiplex Sample-to-Result solution for the detection of the SARS-CoV-2, Flu A, Flu B, and RSV viruses. This achievement was made possible by the dedication and collaboration of all EG teams involved.

About ELITechGroup: ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITechGroup has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient.

 

 

Latest news

NEWSROOM

ELITechGroup Announces Regulatory Approval of its Blood Borne Virus Panel in Japan

ELITechGroup’s blood-borne virus (BBV) panel received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) The ELITe BBV panel was launched in 2022 and comprises three quantitative IVD assays targeting Human Immunodeficiency virus-1 (HIV-1), Human Hepatitis B Virus (HBV), and Human Hepatitis C Virus (HCV) Turin, June 13, 2024: ELITechGroup…

ELITechGroup achieves a new CE-IVDR Certification

ELITechGroup continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories The newly obtained IVDR certificate will expedite the transition to IVDR for quantitative Class C infectious diseases assays The company is fully committed to delivering its entire portfolio of nearly 60 molecular assays as IVDR…

ELITechGroup Launches Second IVDR Certified Gastrointestinal Infection Assay: GI Parasitic PLUS ELITe MGB® Kit 

ELITechGroup launches their second kit of the Gastrointestinal infection assay panel targeting parasitic pathogens.  The ELITe MGB Gastrointestinal assays are IVDR-certified in combination with InGenius and BeGenius, fully automated samples-to-results instruments.  The company will shortly launch two more gastrointestinal assay infection panels targeting viral pathogens and Norovirus.   ELITechGroup announces the…

Let us help you

For general inquiries, please use the links to the right. The Contact link leads to a brief online form, and the Support link offers general phone and email information. Someone will be in touch with you soon.